Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1543
-
Total 13F shares, excl. options
-
971,052,591
-
Shares change
-
-2,676,932
-
Total reported value, excl. options
-
$56,534,223,402
-
Value change
-
-$194,225,396
-
Put/Call ratio
-
1.23%
-
Number of buys
-
617
-
Number of sells
-
-837
-
Price
-
$58.26
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q4 2020
1,787 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q4 2020.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,543 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 971,052,591 shares
of 1,240,722,841 outstanding shares and own 78.27% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (121,672,399 shares), BlackRock Inc. (111,183,334 shares), VANGUARD GROUP INC (102,787,017 shares), STATE STREET CORP (55,206,559 shares), Capital International Investors (46,548,996 shares), Capital World Investors (38,534,588 shares), GEODE CAPITAL MANAGEMENT, LLC (20,078,920 shares), Dodge & Cox (17,107,888 shares), NORTHERN TRUST CORP (15,243,829 shares), and Bank of New York Mellon Corp (13,806,531 shares).
This table shows the top 1543 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.